等待开盘 11-20 09:30:00 美东时间
-0.210
-1.92%
今日重点评级关注:康托·菲茨杰拉德:维持Lexeo Therapeutics"超配"评级,目标价从23美元升至37美元;摩根士丹利:维持Sana Biotechnology"超配"评级,目标价从12美元升至13美元
11-17 17:31
Wells Fargo analyst Zachary Silverberg initiates coverage on Super Group (SGHC) (NYSE:SGHC) with a Equal-Weight rating and announces Price Target of $13.
11-16 21:09
Oppenheimer analyst maintained a Buy rating on Super Group (SGHC) today and set...
11-05 21:27
今日重点评级关注:康托·菲茨杰拉德:维持Supernus"超配"评级,目标价从67美元升至87美元;丰业银行:维持Atlas Energy Solutions"跑赢大市"评级,目标价从17美元升至18美元
11-05 14:06
StoneX analyst Mike Hickey maintains Super Group (SGHC) (NYSE:SGHC) with a Buy and lowers the price target from $20 to $16.
11-04 22:15
今日重点评级关注:摩根士丹利:维持西部数据"超配"评级,目标价从643美元升至668美元;摩根大通:维持西部数据"超配"评级,目标价从600美元升至650美元
10-26 12:30
Barclays analyst Brandt Montour initiates coverage on Super Group (SGHC) (NYSE:SGHC) with a Equal-Weight rating and announces Price Target of $13.
10-23 21:17
今日重点评级关注:DA Davidson:维持美光科技"买入"评级,目标价从2100美元升至3000美元;Leerink Partners:维持OmniAb"跑赢大市"评级,目标价从10美元升至12美元
10-08 12:30
Macquarie analyst Chad Beynon maintains Super Group (SGHC) (NYSE:SGHC) with a Outperform and lowers the price target from $20 to $19.
10-08 00:08
今日重点评级关注:杰富瑞:维持拜玛林制药"买入"评级,目标价从104美元升至105美元;RBC Capital:维持Shift4 Payments"跑赢大市"评级,目标价从63美元升至67美元
09-01 08:37